| Drug Type miRNA | 
| Synonyms NRT-YHD 001, NRT-YHD-001 | 
| Target | 
| Action modulators | 
| Mechanism microRNA let-7i-5p modulators(microRNA let-7i-5p modulators), Epigenetic drug | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Liver Cancer | Preclinical | South Korea  | 22 Mar 2024 | |
| Liver Cancer | Preclinical | South Korea  | 22 Mar 2024 | |
| Hepatocellular Carcinoma | Discovery | South Korea  | 18 Apr 2023 | |
| Hepatocellular Carcinoma | Discovery | South Korea  | 18 Apr 2023 | 





